Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung

Published:2017 Issue:1 Volume:23 Page:19-25
ISSN:1341-1098
Container-title:Annals of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:ATCS

Author:

Isaka Tetsuya¹²,Nakayama Haruhiko¹,Yokose Tomoyuki³,Ito Hiroyuki¹,Katayama Kayoko⁴,Yamada Kouzo⁵,Masuda Munetaka²

Affiliation:

1. Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

2. Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan

3. Department of Pathology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

4. Kanagawa Cancer Center, Research Institute Cancer Prevention & Control Division, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

5. Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

Publisher

Editorial Committee of Annals of Thoracic and Cardiovascular Surgery

Subject

Gastroenterology,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

https://www.jstage.jst.go.jp/article/atcs/23/1/23_oa.16-00164/_pdf

Reference30 articles.

1. 1) Sawabata N, Asamura H, Goya T, et al. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol 2010; 5: 1369-75.

2. 2) Meza R, Meernik C, Jeon J, et al. Lung cancer incidence trends by gender, race and histology in the United States, 1973–2010. PLoS One 2015; 10: e0121323.

3. 3) Maeda R, Yoshida J, Ishii G, et al. Prognostic impact of histology on early-stage non-small cell lung cancer. Chest 2011; 140: 135-45.

4. 4) Fukui T, Taniguchi T, Kawaguchi K, et al. Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma. Gen Thorac Cardiovasc Surg 2015; 63: 507-13.

5. 5) Khan OA, Fitzgerald JJ, Field ML, et al. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung. Ann Thorac Surg 2004; 77: 1173-8.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical Treatment Outcomes of Patients with Non-Small Cell Lung Cancer and Lymph Node Metastases;Cancers;2023-06-07

2. Traditional Treatment Approaches and Role of Immunotherapy in Lung Malignancy and Mesothelioma;Therapeutic Approaches in Cancer Treatment;2023

3. Adjuvant chemotherapy for completely resected IIA–IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice;Translational Lung Cancer Research;2022-12

4. Use of adjuvant chemotherapy in resected non-small cell lung cancer in real-life practice: a systematic review of literature;Translational Lung Cancer Research;2021-12

5. USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma;ELIFE;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3